HXN-2010

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameHXN-2010
Drug Alias NameDLL3 biparatopic, dual-payload ADC (Earendil Labs)HXN-2010
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDelta-like protein 3 modulators
TargetsDelta-like protein 3
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEarendil Labs
China Registration ClassN/A

Develop Information

Active CompaniesEarendil Labs
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A